Results 61 to 70 of about 3,650 (207)

The Incidence of Negative Laparoscopy for Pelvic Pain Stratified by Level of Training and Location of Service Provision

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 3, June 2026.
ABSTRACT Aim Systematic reduction of negative laparoscopy for pelvic pain is crucial to reducing surgical morbidity, improving diagnostic accuracy and minimising cost. This study aims to determine the incidence and consider the underlying causes of negative laparoscopy in women presenting with pelvic pain.
Akshara Shyamsunder, Cecilia Ng, Zaynab El‐Hamawi, David Krones, Erin Nesbitt‐Hawes, Rebecca Deans, Jason Abbott   +6 more
wiley   +1 more source

Engineered Microfluidic Organoid Systems: New Paradigms for Menopause Mechanism Research and Personalized Medicine

Advanced Materials Technologies, Volume 11, Issue 9, 6 May 2026.
This review explores the integration of microfluidic technology with organoid systems as an innovative platform for studying menopausea complex multi‐organ condition. By enabling precise simulation of inter‐organ communication and hormone responses, microfluidic organoids offer a physiologically relevant model for investigating menopausal syndrome and ...
Qianyi Zhang, He Huang, Hongliang Dong, Qiang Ma, Hongyan Jin   +4 more
wiley   +1 more source

Changes in key vaginal bacteria among postpartum African women initiating intramuscular depot-medroxyprogesterone acetate - Fig 3

, 2020
(A) Nugent score, (B) total bacterial load, and (C) concentration of vaginal taxa over time among DMPA-IM users only with fitted trend lines for mean change among all women.
Sujatha Srinivasan (158064), Congzhou Liu (132136), Bridget M. Whitney (8538189), Eric Munene Muriuki (6785672), Brandon L. Guthrie (8538192), Kenneth Tapia (188353), R. Scott McClelland (7456190), Alison C. Roxby (8538201), Bhavna H. Chohan (8538195), Jacqueline M. Wallis (8538198), David N. Fredricks (7423331)   +10 more
core   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate

, 2013
To evaluate contraceptive adherence to the copper intrauterine device (Cu-IUD) and the injectable depot medroxyprogesterone acetate (DMPA) among women with HIV in Lilongwe ...
Tweya, Hannock, Feldacker, Caryl, Hosseinipour, Mina, Jamieson, Denise J., Phiri, Sam, Stuart, Gretchen S., Haddad, Lisa B., Noah, Isaac, Mulundila, Linly, Bryant, Amy G., Mayne, Patrick, Cwiak, Carrie, Samala, Bernadette, Hoffman, Irving   +13 more
core   +1 more source

Novel Approaches for Investigating Host Responses to HIV Infection in Ex Vivo Human Genital Tissues

American Journal of Reproductive Immunology, Volume 95, Issue 5, May 2026.
ABSTRACT Understanding local immune responses and the structural integrity of the genital mucosal barrier is essential for advancing knowledge of both susceptibility to sexual HIV transmission and the pathogenesis of chronic HIV infection. This review highlights innovative methodologies for investigating host responses to HIV infection using ex vivo ...
Mathias Franzén Boger, Vilde Kaldhusdal, Kristina Broliden   +2 more
wiley   +1 more source

Depot Medroxyprogesterone Acetate Contraceptive Injections and Skeletal Health

Women's Health, 2010
This editorial focuses on the effect that depot medroxyprogesterone acetate (DMPA) or Depo-Provera® has on skeletal health. It describes what happens to bone mineral density (BMD) during Depo-Provera® use as well as what happens after Depo-Provera® is discontinued. It also discusses the evidence behind this particular issue but states the importance of
Regina Maria, Renner, Alison B, Edelman, Andrew M, Kaunitz   +2 more
openaire   +2 more sources

Management of secondary amenorrhea induced by injectable contraceptive through Ayurveda: A case report

Journal of Ayurveda Case Reports
Secondary amenorrhea refers to the absence of regular menstrual periods for at least three menstrual cycles with previous regular cycles or for six months with irregular cycles.
Kamini Dhiman, V. Vijila
doaj   +1 more source

Successful treatment of Depot Medroxyprogesterone acetate-related vaginal bleeding improves continuation rates in Adolescents

The Scientific World Journal, 2006
High discontinuation rates for depot medroxyprogesterone acetate (DMPA) in adolescents may contribute to the number of unintended pregnancies. Many cite vaginal bleeding as a reason for discontinuing DMPA use.
Kristin M. Rager, Amy Fowler, Hatim A. Omar   +2 more
doaj   +1 more source

Counting the costs: Comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa

BMC Health Services Research, 2001
Background In South Africa, where health care resources are limited, it is important to ensure that drugs provision and use is rational. The Essential Drug List includes depot medroxyprogesterone acetate (DMPA) and norethisterone oenanthate (NET-EN) as ...
Gray Andrew, Smit Jennifer, McFadyen Lynn, Zuma Khangelani   +3 more
doaj   +1 more source